Hanne Leth Hillman
Presidente en The Danish Investor Relations Society .
Perfil
Hanne Leth Hillman is currently the Co-Chairman at The Danish Investor Relations Society and the Chief Financial Officer at Nanovi Radiotherapy A.
Previously, she held positions such as VP, Director-Investor Relations & Capital Market at NTG Nordic Transport Group A in 2009-2010, Analyst at Gudme Raaschou Bank A in 2004, and Senior VP-Investor Relations & Communications at Zealand Pharma A in 2015-2016.
Ms. Hillman obtained an MBA from the University of Aarhus.
Cargos activos de Hanne Leth Hillman
Empresas | Cargo | Inicio |
---|---|---|
The Danish Investor Relations Society | Presidente | - |
Nanovi Radiotherapy A/S
Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Director Financiero/CFO | 01/05/2017 |
Antiguos cargos conocidos de Hanne Leth Hillman.
Empresas | Cargo | Fin |
---|---|---|
BRAIN+ A/S | Director Financiero/CFO | 01/01/2024 |
ZEALAND PHARMA A/S | Contacto de Relaciones con Inversores | 01/10/2016 |
Gudme Raaschou Bank A/S | Analyst-Equity | 05/11/2004 |
NTG NORDIC TRANSPORT GROUP A/S | Contacto de Relaciones con Inversores | - |
Formación de Hanne Leth Hillman.
University of Aarhus | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
NTG NORDIC TRANSPORT GROUP A/S | Transportation |
ZEALAND PHARMA A/S | Health Technology |
BRAIN+ A/S | Technology Services |
Empresas privadas | 3 |
---|---|
Gudme Raaschou Bank A/S | Finance |
The Danish Investor Relations Society | |
Nanovi Radiotherapy A/S
Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- Hanne Leth Hillman